AiCuris: AiCuris Anti-infective Cures AG: AiCuris Announces Strategic Shift to Focus Development and Commercialization of Anti-infectives for Immunocompromised Patients

Company will advance its highly differentiated product portfolio targeting infections that severely affect immunocompromised patients, including a proprietary phase 3 candidate with fast track to m...